Heart drug tested for structural benefits in Non-Diabetic patients
NCT ID NCT07112274
Summary
This study tested whether empagliflozin, a medication, could improve the structure and function of the heart in non-diabetic patients with a specific type of heart failure. Fifty patients were randomly assigned to receive either empagliflozin or a placebo pill daily for three months. Researchers measured changes in heart size, blood markers of heart stress, and heart function using ultrasound scans to see if the drug helped.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rehab Hussein Werida
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.